- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06316557
High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment (HOPE)
March 12, 2024 updated by: Zi-Xiao Li, Beijing Tiantan Hospital
High-frequency Repetitive Transcranial Magnetic Stimulation on the Cerebellar Hemisphere to Improve Post-stroke Cognitive Impairment
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment.
Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this clinical trial is to investigate the effectiveness and safety of high-frequency repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment.
The trial aims to answer two main questions: (1) What is the effectiveness of high-frequency rTMS in improving post-stroke cognitive impairment?
(2) Is high-frequency rTMS in the cerebellum safe for individuals with post-stroke cognitive impairment?
Participants will undergo 5Hz rTMS in the cerebellar opposite the lesion site, once daily for a total of five days.
The control group will receive sham rTMS with the same parameters and positions.
By comparing the effectiveness of rTMS for post-stroke cognitive impairment between the two groups, researchers will assess the potential benefits of rTMS.
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Weili Jia, Dr.
- Phone Number: 13120207987
- Email: jiawl1994@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Key inclusion criteria:
(1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26;
Key exclusion criteria:
(1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: rTMS group
5Hz rTMS in lesion contralateral cerebellar hemisphere
|
5Hz rTMS in lesion contralateral cerebellar hemisphere, once a day for a total of five days
|
Placebo Comparator: control group
shame rTMS in lesion contralateral cerebellar hemisphere
|
shame rTMS in lesion contralateral cerebellar hemisphere, once a day for a total of five days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The efficacy of rTMS in improving cognitive function of post-stroke cognitive impairment
Time Frame: 3 months follow-up after rTMS treatment
|
The change of MoCA between baseline and 3 months follow-up
|
3 months follow-up after rTMS treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The safety of rTMS in improving cognitive function of post-stroke cognitive impairment
Time Frame: day1-day7
|
Incidence of epilepsy during rTMS treatment
|
day1-day7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zixiao LI, Dr., Beijing Tiantan Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
March 12, 2024
First Submitted That Met QC Criteria
March 12, 2024
First Posted (Actual)
March 18, 2024
Study Record Updates
Last Update Posted (Actual)
March 18, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HX-A-2022063
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Australia, Sweden, Canada, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, China, Greece, Japan, Turkey, Netherlands, Romania, United Kingdom, Portugal, Hungary, Italy, Brazil, France, S... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on rTMS group
-
Institut GuttmannInstituto de Salud Carlos IIICompleted
-
Beni-Suef UniversityCairo UniversityCompleted
-
University of Sao Paulo General HospitalUnknownMild Cognitive ImpairmentBrazil
-
Chinese University of Hong KongIcahn School of Medicine at Mount Sinai; Rudolf Magnus Institute - University...Recruiting
-
Cairo UniversityKasr El Aini HospitalCompletedStroke, CardiovascularEgypt
-
Shanghai Mental Health CenterYunnan Institute For Drug Abuse; Wuxi Mental Health Center, Jiangsu Provence... and other collaboratorsCompletedMethamphetamine-dependenceChina
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University of FloridaNational Institute of Neurological Disorders and Stroke (NINDS)CompletedDystonia | TremorUnited States
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Recruiting
-
Aalborg UniversityCompleted